[1]
SaifM., KaleyK., RodriguezT., and GarconM., “Gemcitabine as Salvage Treatment in Patients with Poorly Differentiated Pancreatic Neuroendocrine Tumors: A Case Series”, JOP, vol. 15, no. 1, pp. 38-41, Jan. 2014.